- August 5, 2025 (Last Earnings): Stock rose 2.1% post-report.
- May 2025: A mixed report led to a 1.5% dip.
How to Buy Pfizer Inc. (PFE) Shares - Investment in Pfizer Inc. (PFE) Stock
Updated on 17 Aug 2025
Pfizer Inc. (PFE) isn’t just a household name—it’s a global powerhouse in the pharmaceutical industry. From life-saving vaccines to blockbuster drugs, Pfizer’s influence is undeniable. If you’re considering adding PFE shares to your portfolio, this breakdown will guide you through the essentials: current stock performance, key risks, and why 2025 might be a pivotal year for the company.
Article navigation
📈 Pfizer Stock: Price, Trends, and What’s Next
As of August 17, 2025, Pfizer (PFE) is trading at $25.14 (Stock Analysis). The stock has shown resilience recently, gaining 3.50% in the past week and 1.8% over the last six months. However, it’s still down 11.06% year-over-year, reflecting some challenges in the broader market.
Key Dates to Watch
Mark your calendar for November 4, 2025—Pfizer’s next earnings report. Historically, earnings releases have moved the stock significantly. For example:
These swings are opportunities for traders who time their moves right.
🔮 Price Forecast: 2025-2030
Here’s where analysts see Pfizer heading:
- 2025 (Year-End): $27-$30 (Potential rebound post-earnings).
- 2026: $32-$35 (Pipeline growth and new drug approvals).
- 2028: $40-$45 (Expansion in emerging markets).
- 2030: $50+ (Long-term stability and innovation).
Verdict: A solid BUY for long-term investors, but short-term traders should wait for post-earnings dips.
⚠️ Key Risks vs. Positive Signals
Risks to Consider
- Regulatory Hurdles: Drug approvals can be unpredictable.
- Patent Cliffs: Key drugs like Eliquis face competition soon.
- Market Volatility: Healthcare stocks can swing with policy changes.
Green Lights for 2025
- Strong Pipeline: New cancer and vaccine treatments in development.
- Global Demand: Vaccines remain a steady revenue stream.
- Cost-Cutting Measures: Pfizer is streamlining operations to boost margins.
🛡️ What Should a Beginner Trader Do Today?
- Start Small: Buy fractional shares if you’re testing the waters.
- Watch Earnings: November 4 could be a game-changer—set alerts!
- Diversify: Don’t put all your eggs in one pharma basket.
- “Trading PFE is like taking medicine—sometimes bitter, but often worth it in the long run.”
✅ How to Buy Pfizer Inc. (PFE) Shares – Step by Step
| Step | Action | Why It Matters |
|---|---|---|
| 1 | Choose a Trading Platform | Ensure it supports NYSE-listed stocks like PFE. |
| 2 | Fund Your Account | Start with as little as $50 for fractional shares. |
| 3 | Search for “PFE” | Use the ticker, not just “Pfizer.” |
| 4 | Select Order Type | Limit orders help avoid overpaying. |
| 5 | Confirm Purchase | Check fees—keep them under 0.5%. |
💡 Why Pocket Option Fits New Investors
Pocket Option makes stock trading accessible:
- Minimum Deposit: $5—perfect for beginners.
- Quick KYC: Verify with just one document and start trading instantly.
- Flexible Withdrawals: Over 100 methods, including crypto and e-wallets.
🌍 Pfizer in 2025: A Pharma Giant with a Mission
Pfizer is more than just COVID vaccines—it’s a leader in oncology, immunology, and rare diseases. With annual revenues topping $60 billion, it’s a staple in any diversified portfolio.
Fun Fact (2025): Pfizer recently partnered with a tech startup to develop AI-powered drug discovery tools—cutting R&D time by 30%!
FAQ
Is Pfizer a good long-term investment?
Yes, especially if you believe in its pipeline and global healthcare demand.
How often does Pfizer pay dividends?
Quarterly—currently yielding around 3.5%.
What’s the biggest risk for PFE stock?
Patent expirations on key drugs like Eliquis.
Can I trade PFE on Pocket Option?
Yes! It’s listed alongside other major stocks.
When is Pfizer’s next earnings report?
November 4, 2025—mark your calendar!
Signals
Sign up for more like this
Customize your newsfeed with content you're actually interested in — get up-to-date personalized newsletter in your inbox.
Your comment
Comments are pre-moderated to ensure they comply with our blog guidelines.